Multicenter Study Evaluating Certolizumab Pegol Compared to Placebo in Subjects With axSpA Without X-ray Evidence of AS
Clinical trial NCT02552212 · COMPLETED
Trial details
- NCT number
- NCT02552212
- Sponsor
- UCB BIOSCIENCES GmbH
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2018-05-01
- Enrollment
- 317
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.